Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG-102(MG12) in Patients With Type 2 Diabetes Mellitus
NCT07677891Phase 2Not yet recruiting
- Sponsor
- PROGEN
- Start
- Oct 2026
- Primary completion
- May 2027
01
Overview
A Phase 2 trial of PG-102 in type 2 diabetes mellitus (T2DM), sponsored by PROGEN. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
PG-102
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07677891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677891.